Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe acute asthma].

Sergio Salmeron1, Marie-Luce Robin, Laurence Kettaneh

  • 1Service de pneumologie Fondation Hôpital Saint-Joseph 75674 Paris. ssalmeron@hopital-saint-joseph.org

La Revue Du Praticien
|June 21, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of ultraviolet germicidal irradiation (UVGI) devices to decrease the incidence of respiratory infections in nursing homes: study protocol for a cluster randomized crossover trial (RESPROTECT).

Trials·2026
Same author

Macrolide maintenance therapy in chronic inflammatory airway diseases: A survey of French pulmonologist's practices.

Respiratory medicine and research·2026
Same author

Transbronchial lung cryobiopsy: a safe and effective technique in the diagnosis of interstitial lung disease in the older people.

BMC geriatrics·2026
Same author

Dyspnoea-referenced minimal clinically important difference in the resting inspiratory capacity response to short-acting bronchodilators in COPD patients.

Pulmonology·2026
Same author

A set of plasmatic microRNA related to innate immune response highly predicts the onset of immune reconstitution inflammatory syndrome in tuberculosis co-infected HIV individuals (ANRS-12358 study).

Frontiers in immunology·2025
Same author

Histoplasma Antigenuria Prevalence in Patients With Advanced HIV Disease in Côte d'Ivoire: A Prospective Trial Ancillary Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Severe acute asthma attacks require prompt treatment with inhaled beta 2 agonists and corticosteroids, often via nebulization. Early response assessment and preventive measures are crucial for avoiding fatalities in asthma exacerbations.

Area of Science:

  • Pulmonology
  • Emergency Medicine
  • Pharmacology

Context:

  • Severe acute asthma attacks are characterized by specific clinical signs or peak expiratory flow (PEF) below 30% predicted.
  • Current treatment primarily involves inhaled beta 2 agonists and systemic corticosteroids, with nebulization as the preferred administration route.

Purpose:

  • To outline the definition, primary treatment strategies, and management principles for severe acute asthma attacks.
  • To emphasize the importance of early treatment response evaluation and preventive measures in managing acute asthma.

Summary:

  • Nebulized beta 2 agonists combined with anticholinergics are recommended for severe asthma exacerbations.
  • Treatment efficacy should be assessed within one hour to identify responders and non-responders.

Related Experiment Videos

  • Preventive strategies, including long-term inhaled corticosteroids and action plans, are vital for reducing asthma-related mortality.

    • Impact:

    • Highlights the critical role of timely and appropriate interventions in improving outcomes for severe acute asthma.
    • Underscores the potential for preventing most asthma-related deaths through effective management and personalized treatment plans.
    • Emphasizes the need for continuous asthma control and preparedness for exacerbations, even in seemingly controlled asthma.